NO313314B1 - Hudpreparat, fremgangsmåte for fremstilling og anvendelse derav - Google Patents
Hudpreparat, fremgangsmåte for fremstilling og anvendelse derav Download PDFInfo
- Publication number
- NO313314B1 NO313314B1 NO19993201A NO993201A NO313314B1 NO 313314 B1 NO313314 B1 NO 313314B1 NO 19993201 A NO19993201 A NO 19993201A NO 993201 A NO993201 A NO 993201A NO 313314 B1 NO313314 B1 NO 313314B1
- Authority
- NO
- Norway
- Prior art keywords
- skin
- mixture
- skin preparation
- carbon atoms
- preparation according
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 135
- 238000000034 method Methods 0.000 title claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000012528 membrane Substances 0.000 claims abstract description 13
- 238000004519 manufacturing process Methods 0.000 claims abstract description 12
- 230000008569 process Effects 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 60
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 49
- 239000000194 fatty acid Substances 0.000 claims description 49
- 229930195729 fatty acid Natural products 0.000 claims description 49
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 48
- 150000004665 fatty acids Chemical class 0.000 claims description 47
- 125000004432 carbon atom Chemical group C* 0.000 claims description 38
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 26
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical group OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims description 26
- 239000006260 foam Substances 0.000 claims description 18
- 239000001267 polyvinylpyrrolidone Substances 0.000 claims description 18
- 229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 18
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 18
- 239000000126 substance Substances 0.000 claims description 18
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 17
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 17
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 17
- 239000000600 sorbitol Substances 0.000 claims description 16
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 15
- 229920001223 polyethylene glycol Polymers 0.000 claims description 15
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 14
- 239000002202 Polyethylene glycol Substances 0.000 claims description 14
- 239000000243 solution Substances 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 10
- 239000013543 active substance Substances 0.000 claims description 9
- 206010040880 Skin irritation Diseases 0.000 claims description 7
- 230000036556 skin irritation Effects 0.000 claims description 7
- 231100000475 skin irritation Toxicity 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 230000035484 reaction time Effects 0.000 claims description 6
- 239000004088 foaming agent Substances 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 3
- 239000000443 aerosol Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 125000005313 fatty acid group Chemical group 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 176
- 238000012360 testing method Methods 0.000 description 49
- 230000001681 protective effect Effects 0.000 description 19
- 239000000047 product Substances 0.000 description 16
- 239000002674 ointment Substances 0.000 description 11
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 9
- 230000003204 osmotic effect Effects 0.000 description 9
- 201000004624 Dermatitis Diseases 0.000 description 8
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 241000699670 Mus sp. Species 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 241000282414 Homo sapiens Species 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 230000004888 barrier function Effects 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 230000000699 topical effect Effects 0.000 description 6
- 241000589562 Brucella Species 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000003755 preservative agent Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 125000003118 aryl group Chemical group 0.000 description 4
- 208000010668 atopic eczema Diseases 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 4
- 210000000170 cell membrane Anatomy 0.000 description 4
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 239000003380 propellant Substances 0.000 description 4
- 230000037394 skin elasticity Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 241001148106 Brucella melitensis Species 0.000 description 3
- 206010006500 Brucellosis Diseases 0.000 description 3
- 241000700198 Cavia Species 0.000 description 3
- 206010012442 Dermatitis contact Diseases 0.000 description 3
- 206010070834 Sensitisation Diseases 0.000 description 3
- 206010070835 Skin sensitisation Diseases 0.000 description 3
- 238000007792 addition Methods 0.000 description 3
- 208000026935 allergic disease Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 229940038698 brucella melitensis Drugs 0.000 description 3
- 239000001273 butane Substances 0.000 description 3
- 208000010247 contact dermatitis Diseases 0.000 description 3
- 239000002085 irritant Substances 0.000 description 3
- 231100000021 irritant Toxicity 0.000 description 3
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 3
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 3
- 230000008313 sensitization Effects 0.000 description 3
- 231100000370 skin sensitisation Toxicity 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 229920000742 Cotton Polymers 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 201000009053 Neurodermatitis Diseases 0.000 description 2
- 208000019462 Occupational injury Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 235000021314 Palmitic acid Nutrition 0.000 description 2
- 229920001213 Polysorbate 20 Polymers 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000003518 caustics Substances 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- 230000009610 hypersensitivity Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 239000004816 latex Substances 0.000 description 2
- 229920000126 latex Polymers 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 2
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 2
- 229940068977 polysorbate 20 Drugs 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 230000000306 recurrent effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000035807 sensation Effects 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 231100001068 severe skin irritation Toxicity 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000005808 skin problem Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000000475 sunscreen effect Effects 0.000 description 2
- 239000000516 sunscreening agent Substances 0.000 description 2
- 238000011200 topical administration Methods 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 101100202529 Danio rerio scoca gene Proteins 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 208000004262 Food Hypersensitivity Diseases 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 229920003081 Povidone K 30 Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000863032 Trieres Species 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000013566 allergen Substances 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229940124326 anaesthetic agent Drugs 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000008280 chlorinated hydrocarbons Chemical class 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000020932 food allergy Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000446 fuel Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 230000004526 pharmaceutical effect Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 231100000046 skin rash Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000009331 sowing Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- -1 surface anaesthetics Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940025703 topical product Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/817—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a single or double bond to nitrogen or by a heterocyclic ring containing nitrogen; Compositions or derivatives of such polymers, e.g. vinylimidazol, vinylcaprolactame, allylamines (Polyquaternium 6)
- A61K8/8176—Homopolymers of N-vinyl-pyrrolidones. Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9700129A SE520811C2 (sv) | 1997-01-17 | 1997-01-17 | Hudskyddspreparat innehållande lipofila och hydrofila komponenter, förfarande för framställning och användning därav |
| PCT/SE1998/000054 WO1998031339A1 (en) | 1997-01-17 | 1998-01-15 | Skin preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO993201D0 NO993201D0 (no) | 1999-06-28 |
| NO993201L NO993201L (no) | 1999-08-26 |
| NO313314B1 true NO313314B1 (no) | 2002-09-16 |
Family
ID=20405448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO19993201A NO313314B1 (no) | 1997-01-17 | 1999-06-28 | Hudpreparat, fremgangsmåte for fremstilling og anvendelse derav |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US5993830A (sv) |
| EP (1) | EP0961610B1 (sv) |
| JP (1) | JP3006572B2 (sv) |
| CN (1) | CN1243431A (sv) |
| AT (1) | ATE283684T1 (sv) |
| AU (1) | AU744980C (sv) |
| BR (1) | BR9806774B1 (sv) |
| CA (1) | CA2278521C (sv) |
| DE (1) | DE69827929T2 (sv) |
| ES (1) | ES2234091T3 (sv) |
| NO (1) | NO313314B1 (sv) |
| PT (1) | PT961610E (sv) |
| RU (1) | RU2196566C2 (sv) |
| SE (1) | SE520811C2 (sv) |
| WO (1) | WO1998031339A1 (sv) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6649174B2 (en) * | 1998-05-07 | 2003-11-18 | E-L Management Corp. | Dual phase cosmetic composition |
| JP2001240533A (ja) | 2000-02-29 | 2001-09-04 | Kao Corp | 経皮投与型製剤 |
| SE0104421D0 (sv) * | 2001-12-21 | 2001-12-21 | Ponsus Pharma Ab | New composition |
| US20050129722A1 (en) * | 2002-03-13 | 2005-06-16 | Collagenex Pharmaceuticals, Inc. | Water-based delivery systems |
| JP4806519B2 (ja) * | 2002-03-13 | 2011-11-02 | トマス スコルド | 水ベースの送達システム |
| IL152486A0 (en) | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| MXPA05004278A (es) † | 2002-10-25 | 2005-10-05 | Foamix Ltd | Espuma cosmetica y farmaceutica. |
| US20080138296A1 (en) | 2002-10-25 | 2008-06-12 | Foamix Ltd. | Foam prepared from nanoemulsions and uses |
| US9265725B2 (en) | 2002-10-25 | 2016-02-23 | Foamix Pharmaceuticals Ltd. | Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| US10117812B2 (en) | 2002-10-25 | 2018-11-06 | Foamix Pharmaceuticals Ltd. | Foamable composition combining a polar solvent and a hydrophobic carrier |
| US7700076B2 (en) | 2002-10-25 | 2010-04-20 | Foamix, Ltd. | Penetrating pharmaceutical foam |
| US7704518B2 (en) | 2003-08-04 | 2010-04-27 | Foamix, Ltd. | Foamable vehicle and pharmaceutical compositions thereof |
| US9668972B2 (en) | 2002-10-25 | 2017-06-06 | Foamix Pharmaceuticals Ltd. | Nonsteroidal immunomodulating kit and composition and uses thereof |
| AU2003293865A1 (en) * | 2002-12-12 | 2004-06-30 | Allpresan Gesellschaft Zum Vertrieb Von Gesundheitsprodukten Fur Allergiker Mbh | Stable foam cream |
| ITMI20030343A1 (it) * | 2003-02-26 | 2004-08-27 | Biofarm S R L Ora Biofarmitalia S P A | Gel cosmetico o curativo applicabile sulla pelle umana. |
| MX2009000507A (es) | 2006-07-14 | 2009-06-12 | Stiefel Res Australia Pty Ltd | Espuma farmaceutica de acidos grasos. |
| US20080260655A1 (en) | 2006-11-14 | 2008-10-23 | Dov Tamarkin | Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses |
| EP2115052A4 (en) * | 2007-01-19 | 2013-01-09 | Ponsus Pharma Ab | UREA-FOAM |
| US8636982B2 (en) | 2007-08-07 | 2014-01-28 | Foamix Ltd. | Wax foamable vehicle and pharmaceutical compositions thereof |
| US20090068117A1 (en) * | 2007-09-04 | 2009-03-12 | Quinnova Pharmaceuticals, Inc. | Stay-on selenium foam |
| WO2009069006A2 (en) | 2007-11-30 | 2009-06-04 | Foamix Ltd. | Foam containing benzoyl peroxide |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| EP2355796A4 (en) * | 2008-10-15 | 2012-04-25 | Quinnova Pharmaceuticals Inc | salicylic acid composition |
| WO2010125470A2 (en) | 2009-04-28 | 2010-11-04 | Foamix Ltd. | Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof |
| CA2769677A1 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses |
| WO2011013009A2 (en) | 2009-07-29 | 2011-02-03 | Foamix Ltd. | Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses |
| US9849142B2 (en) | 2009-10-02 | 2017-12-26 | Foamix Pharmaceuticals Ltd. | Methods for accelerated return of skin integrity and for the treatment of impetigo |
| CA2776474C (en) | 2009-10-02 | 2021-01-12 | Foamix Ltd. | Topical tetracycline compositions |
| US8409628B2 (en) * | 2010-02-04 | 2013-04-02 | Penguin IP Holdings, Inc. | Methods and compositions for oxygenation of skin to treat skin disorders |
| US9358209B2 (en) * | 2010-10-26 | 2016-06-07 | Exeltis Usa Dermatology, Inc. | Econazole composition and methods of treatment therewith |
| WO2012057895A2 (en) | 2010-10-26 | 2012-05-03 | Quinnova Pharmaceuticals, Inc. | Composition and method for treating wounds |
| DE102011018924A1 (de) | 2011-04-28 | 2012-10-31 | Tunap Industrie Chemie Gmbh & Co. Produktions Kg | OW-Emulsionskonzentrat, Verfahren zu dessen Herstellung und dieses enthaltendes Hautkosmetikum |
| US8893443B2 (en) * | 2012-02-07 | 2014-11-25 | Tait Towers Manufacturing, LLC | Support structure with stowed implement bracket |
| US10406088B2 (en) | 2015-01-20 | 2019-09-10 | TetraDerm Group LLC | Versatile topical drug delivery vehicle and multifactorial tissue moisturizer that provides mucosal and skin barrier restoration |
| US10369116B2 (en) * | 2015-03-02 | 2019-08-06 | Hisamitsu Pharmaceutical Co., Inc. | Patch comprising an adhesive layer having a nonfunctional silicone oil |
| MX2020012139A (es) | 2016-09-08 | 2021-01-29 | Vyne Pharmaceuticals Inc | Composiciones y metodos para tratar rosacea y acne. |
| EP3482742A1 (en) | 2017-11-10 | 2019-05-15 | Paragon Nordic AB | Foamable skin composition |
| CN114452228B (zh) * | 2022-04-14 | 2022-06-21 | 新基元(北京)医药科技有限公司 | 一种用于洗发的二硫化硒泡沫剂及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3298919A (en) * | 1962-12-26 | 1967-01-17 | Dow Corning | Shaving cream containing polysiloxanes |
| GB2069333A (en) * | 1980-02-19 | 1981-08-26 | Hasbro Industries Inc | Cosmetic composition |
| US4857328A (en) * | 1986-09-29 | 1989-08-15 | Tecma Laboratories, Inc. | Skin therapeutic mixture containing aloe vera extract |
| US4900550A (en) * | 1987-08-19 | 1990-02-13 | Amy Allene Cosmetiques, Inc. | Skin care cosmetic regime |
| US5008100A (en) * | 1989-08-11 | 1991-04-16 | Elizabeth Arden Co., Division Of Conopco, Inc. | Oil-in-water emulsions containing polyethylene |
| AU8305391A (en) * | 1990-10-18 | 1992-05-20 | Isp Investments Inc. | Swellable, crosslinked polyvinylpyrrolidone and cosmetic compositions therewith |
| US5208013A (en) * | 1991-06-03 | 1993-05-04 | Olympus International, Inc. | Composition for skin care and protection |
| FR2722403B1 (fr) * | 1994-07-15 | 1996-09-20 | Biolog Vegetable Yves Rocher L | Composition cosmetique pour la constitution de batons pour les levres ou la peau et leurs procedes de preparation |
| IL110380A0 (en) * | 1994-07-20 | 1994-10-21 | Agis Ind 1983 Ltd | Antiviral topical pharmaceutical compositions |
| FR2737117B1 (fr) * | 1995-07-25 | 1997-09-05 | Oreal | Composition sous forme de pate souple obtenue par extrusion et procede de preparation |
-
1997
- 1997-01-17 SE SE9700129A patent/SE520811C2/sv not_active IP Right Cessation
-
1998
- 1998-01-12 JP JP10037891A patent/JP3006572B2/ja not_active Expired - Fee Related
- 1998-01-15 ES ES98901623T patent/ES2234091T3/es not_active Expired - Lifetime
- 1998-01-15 CA CA002278521A patent/CA2278521C/en not_active Expired - Lifetime
- 1998-01-15 RU RU99117924/14A patent/RU2196566C2/ru not_active IP Right Cessation
- 1998-01-15 EP EP98901623A patent/EP0961610B1/en not_active Expired - Lifetime
- 1998-01-15 AU AU57861/98A patent/AU744980C/en not_active Ceased
- 1998-01-15 AT AT98901623T patent/ATE283684T1/de active
- 1998-01-15 PT PT98901623T patent/PT961610E/pt unknown
- 1998-01-15 CN CN98801871A patent/CN1243431A/zh active Pending
- 1998-01-15 WO PCT/SE1998/000054 patent/WO1998031339A1/en active IP Right Grant
- 1998-01-15 BR BRPI9806774-5A patent/BR9806774B1/pt not_active IP Right Cessation
- 1998-01-15 DE DE69827929T patent/DE69827929T2/de not_active Expired - Lifetime
- 1998-01-16 US US09/008,632 patent/US5993830A/en not_active Expired - Lifetime
-
1999
- 1999-06-28 NO NO19993201A patent/NO313314B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| AU744980C (en) | 2003-04-17 |
| AU744980B2 (en) | 2002-03-07 |
| BR9806774B1 (pt) | 2012-09-04 |
| DE69827929D1 (de) | 2005-01-05 |
| EP0961610A1 (en) | 1999-12-08 |
| CA2278521A1 (en) | 1998-07-23 |
| JP3006572B2 (ja) | 2000-02-07 |
| ES2234091T3 (es) | 2005-06-16 |
| EP0961610B1 (en) | 2004-12-01 |
| BR9806774A (pt) | 2000-05-16 |
| AU5786198A (en) | 1998-08-07 |
| RU2196566C2 (ru) | 2003-01-20 |
| JPH10226637A (ja) | 1998-08-25 |
| DE69827929T2 (de) | 2005-11-24 |
| NO993201L (no) | 1999-08-26 |
| SE9700129L (sv) | 1998-07-18 |
| NO993201D0 (no) | 1999-06-28 |
| CN1243431A (zh) | 2000-02-02 |
| WO1998031339A1 (en) | 1998-07-23 |
| US5993830A (en) | 1999-11-30 |
| PT961610E (pt) | 2005-04-29 |
| SE520811C2 (sv) | 2003-08-26 |
| ATE283684T1 (de) | 2004-12-15 |
| SE9700129D0 (sv) | 1997-01-17 |
| CA2278521C (en) | 2005-12-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO313314B1 (no) | Hudpreparat, fremgangsmåte for fremstilling og anvendelse derav | |
| US20060105059A1 (en) | Fruit and/or vegetable derived composition | |
| KR20190122854A (ko) | 국소 조성물 및 사용 방법 | |
| CN105395442A (zh) | 一种天然植物长效保湿组合物及其用途 | |
| JPH09157176A (ja) | オトギリソウ、ボダイジュ抽出物含有抗アレルギー剤、 皮膚外用剤及び浴用剤 | |
| JP2010522757A (ja) | 哺乳動物外皮の皮膚炎症状の皮膚軟化殺菌製剤による処置 | |
| CN108014032A (zh) | 一种护臀湿巾及其制备方法 | |
| JPH05117158A (ja) | 皮膚外用剤組成物 | |
| CN108125797A (zh) | 一种手口湿巾及其制备方法 | |
| Harman | Dermatitis cruris pustulosa et atrophicans, the Nigerian shin disease | |
| Kulawik-Pióro et al. | Determining the quality of hydrophobic barrier creams by rheological measurements, sensory analysis, pH determination and permeation time measurements | |
| CN105534830B (zh) | 一种绷带式体膜和身体皮肤的保养方法 | |
| CN108186440A (zh) | 可抗菌护肤的中药植物沐浴露及其制备方法和用途 | |
| Douglas et al. | Hair care products used by women of African descent: review of ingredients | |
| JP2019529447A (ja) | 特定の界面活性剤および高濃度のグリセリンを含む組成物 | |
| CN105496818A (zh) | 祛斑护肤化妆品 | |
| EA009549B1 (ru) | Барьерная композиция, способ ее получения и применение | |
| SUTTON et al. | Dermatitis of the hands: Etiology and principles of treatment, with observations concerning a hyperkeratotic dermatitis of the volar skin | |
| Álvarez‐Cuesta et al. | Occupational asthma and IgE‐mediated contact dermatitis from sapele wood | |
| US20230255862A1 (en) | Composition for application to a surface of skin of a user | |
| JP2000281553A (ja) | 殺菌消毒剤組成物 | |
| Mullaicharam et al. | Evaluation of anti-acne property of poly herbal formulation | |
| RU2227016C1 (ru) | Состав для ванн | |
| WO2022139746A2 (en) | Composition containing natural vegetable oils and skin care product comprising said composition | |
| Mitchell | Need for Research in the Treatment of Epidermophytoses |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK1K | Patent expired |